Bumrungrad Hospital Public Company Limited (BZ7A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bumrungrad Hospital Public Company Limited (BZ7A) has a cash flow conversion efficiency ratio of 0.067x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.10 Billion ≈ $2.45 Billion USD) by net assets (€31.17 Billion ≈ $36.44 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bumrungrad Hospital Public Company Limited - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Bumrungrad Hospital Public Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Bumrungrad Hospital Public Company Limit (BZ7A) total liabilities for a breakdown of total debt and financial obligations.
Bumrungrad Hospital Public Company Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bumrungrad Hospital Public Company Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tiger Royalties and investments Plc
LSE:TIR
|
-0.272x |
|
Bangkok Bank Public Company Limited
F:BKKF
|
0.014x |
|
Hamak Gold Ltd
LSE:HAMA
|
0.000x |
|
Allianz Malaysia Bhd
KLSE:1163PA
|
0.001x |
|
Coro Energy PLC
LSE:CORO
|
-0.278x |
|
Catenai PLC
LSE:CTAI
|
-0.188x |
|
Norman Broadbent Plc
LSE:NBB
|
0.147x |
|
N4 Pharma PLC
LSE:N4P
|
-0.251x |
Annual Cash Flow Conversion Efficiency for Bumrungrad Hospital Public Company Limited (2016–2025)
The table below shows the annual cash flow conversion efficiency of Bumrungrad Hospital Public Company Limited from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Bumrungrad Hospital Public Company Limit market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €31.17 Billion ≈ $36.44 Billion |
€8.25 Billion ≈ $9.65 Billion |
0.265x | -15.11% |
| 2024-12-31 | €27.80 Billion ≈ $32.50 Billion |
€8.67 Billion ≈ $10.14 Billion |
0.312x | +2.39% |
| 2023-12-31 | €24.10 Billion ≈ $28.17 Billion |
€7.34 Billion ≈ $8.58 Billion |
0.305x | -1.91% |
| 2022-12-31 | €20.01 Billion ≈ $23.39 Billion |
€6.21 Billion ≈ $7.26 Billion |
0.311x | +53.85% |
| 2021-12-31 | €17.62 Billion ≈ $20.60 Billion |
€3.56 Billion ≈ $4.16 Billion |
0.202x | +68.20% |
| 2020-12-31 | €18.84 Billion ≈ $22.02 Billion |
€2.26 Billion ≈ $2.64 Billion |
0.120x | -50.34% |
| 2019-12-31 | €20.27 Billion ≈ $23.69 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.242x | -4.31% |
| 2018-12-31 | €18.74 Billion ≈ $21.91 Billion |
€4.73 Billion ≈ $5.53 Billion |
0.253x | -19.54% |
| 2017-12-31 | €16.70 Billion ≈ $19.53 Billion |
€5.24 Billion ≈ $6.13 Billion |
0.314x | -10.28% |
| 2016-12-31 | €14.79 Billion ≈ $17.29 Billion |
€5.17 Billion ≈ $6.05 Billion |
0.350x | -- |
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic,… Read more